COPD exacerbations announce themselves before the patient calls. Oxygen saturation drifts, reliever use climbs and symptom scores worsen days ahead of the visit that would have caught it. HealthArc puts that signal in front of your care team while it is still treatable at home.
Remote patient monitoring for COPD is the practice of collecting oxygen saturation, symptom scores and lung-function data from a patient at home, reviewing it against thresholds you set, and acting on it between office visits. For COPD specifically the value is timing. A patient whose SpO2 has slipped for three consecutive days and whose reliever use has doubled is heading for an exacerbation, and that is a very different clinical event depending on whether you find it on day three or day nine.
Found early, it’s usually a phone call, a steroid or antibiotic course and a follow-up. Found late, it is an emergency department visit and often an admission. COPD is one of the conditions where readmission penalties bite hardest, which is why the monitoring and the post-discharge follow-up are usually built together.
HealthArc supplies the cellular devices, the alerting, the care-team workflow and the billing documentation. Your team can run it, or our clinical pod can run it under your supervising provider’s name and NPI.
The window is the whole point. Monitoring nobody reviews inside 24–48 hours gives back most of the benefit. Decide who owns the alert queue before you decide which device to ship.
The four signals below are what most COPD programs run on, and what your alert rules key off.
| Signal | Device | Common alert threshold | What the team does |
|---|---|---|---|
| SpO2 | Cellular pulse oximeter | < 92%, or a 3–4 point drop from the patient’s own baseline | Same-day call. Confirm technique, check symptoms, decide on rescue therapy. |
| FEV1 / peak flow | Home spirometer | >10–15% decline against personal best | Review trend, consider steroid or antibiotic course, bring the visit forward. |
| Symptom score | App or SMS check-in (RTM) | Worsening breathlessness, sputum colour or volume | Structured triage against the patient’s action plan. |
| Reliever use | Adherence sensor on the inhaler | Doubling of usual daily actuations | Earliest of the four signals in many patients. Prompts a check-in call. |
| Temperature | Connected thermometer | > 100.4°F during a suspected flare | Infection workup rather than a bronchodilator adjustment. |
Alert thresholds are configured per patient by the ordering clinician and adjusted over time. The values above are common starting points, not clinical guidance, and nothing here establishes a standard of care. Reimbursement figures are approximate national non-facility Medicare averages and vary by locality, facility status, payer and calendar year: verify current rates at cms.gov or with your MAC before you bill.
All cellular. No Wi-Fi, no app, no pairing, and nothing for the patient to set up.
SpO2 and pulse in under 30 seconds over LTE-M, trended so a decline shows up early.
RPM 99454FEV1, FVC and peak flow with on-device coaching, trended against personal best.
RTM 98976Per-patient fever thresholds with same-day alerts.
RPM 99454For the large share of COPD patients who also carry hypertension.
RPM 99454Most COPD panels support more than one. The codes stack when the time is tracked separately.
Device supply plus monthly treatment-management time for the physiologic data.
99453 · 99454 · 99457COPD plus a second chronic condition, which most of these patients have.
99490 · 99439When COPD alone drives the care burden and CCM’s two-condition test is not met.
99424–99427The 30 days after a COPD admission, where readmission risk concentrates.
99495 · 99496Respiratory device supply and symptom/adherence data.
98976 · 98980Same shape every month, which is what makes it auditable.
We screen your panel for COPD patients by diagnosis code and payer, then capture consent electronically with a timestamped record.
A cellular oximeter, and a spirometer where lung function is being trended, arrives at the patient’s door already activated.
There’s nothing for the patient to do beyond the measurement. Transmission is automatic, and the platform counts days toward the 16-of-30 threshold.
Out-of-range readings surface with the patient’s trend and history attached. Every contact is logged against the code it supports.
Time, consent and transmission days are already documented, so the billing record builds itself instead of being reconstructed.
Remote patient monitoring for COPD is a Medicare-reimbursable program in which a patient uses connected devices at home, most commonly a cellular pulse oximeter and often a spirometer, to send oxygen saturation, lung function and symptom data to their care team between visits. The team reviews the readings against thresholds the clinician sets and intervenes when a trend suggests an exacerbation is developing.
The clinical case rests on timing: the physiological signal typically precedes how the patient feels by several days, which is the window in which treatment at home can replace a hospital stay.
Four signals do most of the work:
Temperature is frequently added during a suspected flare to separate infection from bronchospasm.
The physiologic data is billed under RPM: 99453 for setup and patient education, 99454 for device supply (which requires readings on at least 16 of 30 days), and 99457 plus 99458 for monthly treatment-management time. Symptom and adherence data is billed under RTM instead (98976, 98980, 98981).
Most COPD patients also carry a second chronic condition, so CCM (99490, 99439) is billable alongside RPM in the same month provided the minutes are tracked separately and never counted twice. See the full RPM code reference.
Published work on exacerbation prediction consistently finds a physiological lead time of several days before a patient self-reports feeling unwell, with declining SpO2, falling peak flow and rising reliever use as the usual early markers. Programs typically plan around a three-to-five day window.
That window only converts into avoided admissions if somebody reviews and acts on the alert within a day or two. The monitoring is necessary; the staffed alert queue is what makes it work.
No. Every device HealthArc ships for COPD transmits over its own 4G cellular connection with 2G fallback and a multicarrier SIM. There’s no app to install, no Bluetooth pairing, no home broadband and no account for the patient to create.
That matters more in COPD than in most conditions, because the patients at highest risk skew older and are the least likely to own a smartphone or have reliable home internet. That’s exactly the group a Bluetooth-and-app program quietly fails to enrol.
Yes. With the managed-services option a HealthArc clinical pod of RNs, LPNs, medical assistants and enrolment specialists runs enrolment, daily review, outreach and documentation under your supervising provider’s name and NPI. Your clinicians keep every clinical decision and sign off on billing.
Practices with existing care-coordinator capacity often run it themselves on the platform, and plenty run a hybrid where we absorb overflow and after-hours attempts.
Bring your COPD patient count and we’ll model the billable population, the device mix and the monthly reimbursement before you commit to anything.
Practical guidance on remote monitoring, devices and billing. Updated with every new post.
Compare RPM and CCM platforms on the five things that decide real-world performance, then implement an RPM program step by step with 2026 CPT rates.
Read articleCellular or Bluetooth for RPM blood pressure? What CPT 99445 changed in 2026, why 78% of over-65s owning a smartphone breaks the usual argument, and how to match devices per patient.
Read articleA measure-by-measure map of what RPM, CCM and APCM can actually influence, the CBP specification detail most programs miss, and why PDC targeting should start at 79%.
Read articleInterested in a demo or just general questions? Fill out the form below and a representative will respond shortly!
